Skip to main
NGVT

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp has a positive outlook due to management's strategic asset sale, which aims to enhance the company's portfolio by minimizing operational distractions. This action is anticipated to decrease earnings volatility while simultaneously improving the margin profile of the business. Furthermore, the consistent execution of these strategic initiatives suggests a strong potential for revenue growth across its core segments, particularly in Performance Chemicals, where the majority of revenue is generated.

Bears say

Ingevity Corp faces potential earnings challenges due to concerns over a second decline in global automobile production, which may hinder its ability to transition its customer base towards alternative fuel applications (AFA). Additionally, the company's margins are projected to remain low, in the 4-5% range, further complicating its financial outlook given the higher-than-expected transaction multiples associated with recent proceeds. The overall risk landscape includes uncertainties related to patent expirations, trade tariffs affecting the Performance Materials segment, and external competitive pressures that could jeopardize margin stability.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Jan 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $67.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $67.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.